UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Steven Madden
SHOO
$3.57B
| $2.84M | ﹤0.01% |
88,928
-925
| -1% | -$28.9K |
|
1327
Liberty Energy
LBRT
$3.46B
| $2.84M | ﹤0.01% |
177,492
+26,514
| +18% | +$422K |
|
1328
Boston Beer
SAM
$1.86B
| $2.84M | ﹤0.01% |
8,611
| – | – |
|
1329
Papa John's
PZZA
$768M
| $2.82M | ﹤0.01% |
34,315
-403
| -1% | -$31.7K |
|
1330
Outset Medical
OM
$94.9M
| $2.82M | ﹤0.01% |
7,284
+1,191
| +20% | +$336K |
|
1331
Driven Brands
DRVN
$2.08B
| $2.81M | ﹤0.01% |
102,903
+7,068
| +7% | +$211K |
|
|
TPH
1332
DELISTED
Tri Pointe Homes
TPH
| $2.81M | ﹤0.01% |
151,154
+542
| +0.4% | +$9.42K |
|
|
ENV
1333
DELISTED
ENVESTNET, INC.
ENV
| $2.8M | ﹤0.01% |
45,379
-6,709
| -13% | -$357K |
|
1334
Champion Homes
SKY
$5.06B
| $2.8M | ﹤0.01% |
54,274
+6,706
| +14% | +$357K |
|
1335
Plexus
PLXS
$7.23B
| $2.79M | ﹤0.01% |
27,084
-1,812
| -6% | -$183K |
|
1336
Array Technologies
ARRY
$822M
| $2.79M | ﹤0.01% |
144,213
+19,997
| +16% | +$380K |
|
1337
New Fortress Energy
NFE
$97.5M
| $2.79M | ﹤0.01% |
65,711
-11,798
| -15% | -$570K |
|
1338
Minerals Technologies
MTX
$2.32B
| $2.78M | ﹤0.01% |
45,824
+6,766
| +17% | +$383K |
|
1339
UiPath
PATH
$7.97B
| $2.78M | ﹤0.01% |
218,642
-9,500
| -4% | -$117K |
|
1340
Diageo
DEO
$53.6B
| $2.77M | ﹤0.01% |
15,528
-1,500
| -9% | -$263K |
|
|
ONEM
1341
DELISTED
1Life Healthcare
ONEM
| $2.76M | ﹤0.01% |
165,237
+4,532
| +3% | +$76.6K |
|
1342
Arcosa
ACA
$7.11B
| $2.76M | ﹤0.01% |
50,807
-399
| -0.8% | -$23.7K |
|
1343
Enpro
NPO
$7B
| $2.74M | ﹤0.01% |
25,247
-180
| -0.7% | -$19.5K |
|
1344
Piper Sandler
PIPR
$5.27B
| $2.74M | ﹤0.01% |
84,048
| – | – |
|
1345
Mercury Systems
MRCY
$6.53B
| $2.74M | ﹤0.01% |
61,141
-2,394
| -4% | -$113K |
|
1346
CONMED
CNMD
$1.49B
| $2.73M | ﹤0.01% |
30,827
| – | – |
|
1347
Progress Software
PRGS
$1.77B
| $2.72M | ﹤0.01% |
53,958
-259
| -0.5% | -$12.9K |
|
|
CALY
1348
Callaway Golf Company
CALY
$3.08B
| $2.72M | ﹤0.01% |
137,769
+3,153
| +2% | +$62.1K |
|
|
ESGR
1349
DELISTED
Enstar Group
ESGR
| $2.71M | ﹤0.01% |
11,729
-551
| -4% | -$112K |
|
1350
FirstCash
FCFS
$9.05B
| $2.71M | ﹤0.01% |
31,127
| – | – |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.